Ispire Technology (ISPR) investor relations material

Executive summary

• Revenue for Q3 FY2026 was $18.7M, down 28.7% year-over-year and sequentially, reflecting stabilization after strategic repositioning and improved operating discipline.

• Net loss for the quarter was $9.5M ($0.17/share), improved from $10.9M year-over-year but higher than the prior quarter.

• Cash increased by $468K sequentially to $18M, with improved financial control and working capital at $0.9M as of March 31, 2026.

• Malaysia manufacturing platform launched, providing a 25% tariff advantage and regulatory exclusivity as the only licensed nicotine vapor manufacturer in the country.

• Transition phase completed; now executing a phased growth roadmap with catalysts in large markets and a focus on profitability and cash flow positive in the second half of 2026.

Financial highlights

• Revenue for the quarter was $18.7M, and for the nine months ended March 31, 2026, $69.3M, both down year-over-year.

• Gross profit for the quarter was $2.0M (10.7% margin), impacted by $2.2M in one-time product returns from legacy cannabis customers.

• Operating expenses (excluding credit loss/bad debt) were $5.9M, down 36% year-over-year and 3.7% sequentially.

• Net loss for the nine months was $19.4M, improved from $24.5M in the prior year.

• Net cash used in operating activities for the quarter was $319K, a significant improvement from the prior year.

Outlook and guidance

• Targeting cash flow positive in the second half of 2026, with management also projecting positive cash flow in early fiscal 2027.

• Q3 expected to be the low point for both top and bottom line, with an upward trajectory anticipated.

• Revenue growth expected from Malaysian manufacturing and new revenue catalysts, with continued cost reductions.